Viewing Study NCT07470203


Ignite Creation Date: 2026-03-26 @ 3:16 PM
Ignite Modification Date: 2026-03-30 @ 12:09 AM
Study NCT ID: NCT07470203
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-03-13
First Post: 2026-03-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pyrotinib Combined With Trastuzumab and Pertuzumab for Maintenance Therapy in HER2-Positive Advanced Breast Cancer
Sponsor: Peking University Cancer Hospital & Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module